Ticlopidine-associated thrombotic-thrombocytopenic purpura (Moschcowitz' disease);Ticlopidin-assoziierte thrombotisch-thrombozytopenische purpura (Morbus Moschcowitz)

Medizinische Klinik

Volumn 95, Issue 1, 2000, Pages 44-48

  Carlsson, Jörg ^a   Miketic, Sinisa ^b   Bätge, Rolf ^b   Riedel, Petra ^b   Rahlf, Günther ^b   Tebbe, Ulrich ^b  

^a KERCKHOFF HEART CENTER   (Germany)

^b NONE

Author keywords

Morbus Moschcowitz; Thrombotic thrombocytopenic purpura; Ticlopidine

Indexed keywords

TICLOPIDINE;

AGED; ARTICLE; CASE REPORT; FEMALE; HEMOLYTIC ANEMIA; HUMAN; KIDNEY FAILURE; PLASMA TRANSFUSION; PLASMAPHERESIS; SYMPTOMATOLOGY; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

POMACANTHUS MACULOSUS; PURPURA;

EID: 0034650840     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03044980     Document Type: Article

References (26)

1. Ariyoshi K, Shinohara K, Ruirong X. Thrombotic thrombocytopenic purpura caused by ticlopidine, successfully treated by plasmapheresis. Am J Hematol 1997;54:175-6.
2. Arzneimittelkommission der deutschen Ärzteschaft. Thrombotisch-thrombozytopenische Purpura. Dtsch Ärztebl 1999;96:128.
3. Bell WR, Braine HG, Ness PM, et al. Improved survival in thrombotic thrombocytopenic purpura - hemolytic uremic syndrome. N Engl J Med 1991;325:398-403.
4. Bennett CL, Weinberg PD, Rozenberg-Ben-Dror K, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases. Ann Intern Med 1998;128:541-4.
5. Bennett CL, Kiss JE, Weinberg PD, et al. Thrombotic thrombocytopenic purpura after stenting and ticlopidine. Lancet 1998;352:1036-7.
6. Bennett CL, Green D, Kwaan HC, et al. Ticlopidine associated thrombotic thrombocytopenic purpura following cardiac stent placement. N Engl J Med (in press).
7. Bithell TC. Thrombotic thrombocytopenic purpura and other forms of nonimmunologic platelet destruction. In: Lee, Bihell, Foerster, Athens, et al., eds. Wintrobe's clinical hematology, 9th edn. Philadelphia-London: Lea & Febiger, 1993:1356-62.
8. Bobbio-Pallavicini E, Gugliottta L, Centurioni R., et al. Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP. Haematologica 1997;82:429-35.
9. Capra R, Marciano N, Fieni F, et al. Cerebral hemorrhage and thrombotic thrombocytopenic purpura during ticlopidine treatment: case report. Acta Neurol Belg 1992;92:83-7.
10. Elli E, Durrieu C, Besse P, et al. Thrombotic thrombocytopenic purpura associated with ticlopidine. Stroke 1992;23:922-3.
11. Furlan M, Robles R, Galbusera M, et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. M Engl J Med 1998;339:1578-84.
12. Hass WK, Easton JD, Adams HP, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;321:501-7.
13. Kovacs MJ, Soong PY, Chin-Hee IH. Thrombotic thrombocytopenic purpura associated with ticlopidine. Ann Pharmacother 1993;27:1060-1.
14. Kupfer Y, Tessler S. Ticlopidine and thrombotic thrombocytopenic purpura. N Engl J Med 1997;337:1245.
15. Mallet L, Mallett J. Ticlopidine and fatal aplastic anemia in an elderly women. Ann Pharmacother 1994;28:1169-71.
16. Moake JL. TTP - desperation, empiricism, progress. N Engl J Med 1991;325:426-8.
17. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaris: a hitherto undescribed disease. Proc NY Pathol Soc 1924;24:21-4.
18. Page Y, Tardy B, Zeni F, et al. Thrombotic Thrombocytopenic purpura related to ticlopidine. Lancet 1991; 337:774-6.
19. Rock GA, Shumak KH, Buskard NA, et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991;325:393-7.
20. Rose M, Eldor A. High incidence of relapse in thrombotic thrombocytopenic purpura. Clinical study of 38 patients. Am J Med 1987;83:437-44.
21. Schömig A, Neumann FJ, Kastrati A, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996;334:1084-9.
22. Shapiro CM, Walk D. Aplastic anemia associated with ticlopidine. Neurology (NY) 1996;47:300.
23. Su CC, Tseng CD, Hwang JJ, et al. Severe aplastic anemia induced by ticlopidine: report of a case. J Formos Med Assoc 1995;94:689-91.
24. Tsai H-M, Lian EC-Y. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic-thrombocytopenic purpura. N Engl J Med 1998;339: 1585-94.
25. Weiner P, Zidan F, Paz R. Severe aplastic anemia due to ticlopidine. Isr J Med Sci 1995;31: 444-5.
26. Wysowksi DK, Bacsanyi J. Blood dycrasias and hematologic reactions in ticlopidine users. J Am Med Ass 1996; 276:952.